13-75292197-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014832.5(TBC1D4):āc.3391A>Gā(p.Ile1131Val) variant causes a missense change. The variant allele was found at a frequency of 0.000328 in 1,613,584 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 32)
Exomes š: 0.00034 ( 3 hom. )
Consequence
TBC1D4
NM_014832.5 missense
NM_014832.5 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.83
Genes affected
TBC1D4 (HGNC:19165): (TBC1 domain family member 4) This gene is a member of the Tre-2/BUB2/CDC16 domain family. The protein encoded by this gene is a Rab-GTPase-activating protein, and contains two phopshotyrosine-binding domains (PTB1 and PTB2), a calmodulin-binding domain (CBD), a Rab-GTPase domain, and multiple AKT phosphomotifs. This protein is thought to play an important role in glucose homeostasis by regulating the insulin-dependent trafficking of the glucose transporter 4 (GLUT4), important for removing glucose from the bloodstream into skeletal muscle and fat tissues. Reduced expression of this gene results in an increase in GLUT4 levels at the plasma membrane, suggesting that this protein is important in intracellular retention of GLUT4 under basal conditions. When exposed to insulin, this protein is phosphorylated, dissociates from GLUT4 vesicles, resulting in increased GLUT4 at the cell surface, and enhanced glucose transport. Phosphorylation of this protein by AKT is required for proper translocation of GLUT4 to the cell surface. Individuals homozygous for a mutation in this gene are at higher risk for type 2 diabetes and have higher levels of circulating glucose and insulin levels after glucose ingestion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008725405).
BP6
Variant 13-75292197-T-C is Benign according to our data. Variant chr13-75292197-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 3057756.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D4 | NM_014832.5 | c.3391A>G | p.Ile1131Val | missense_variant | 19/21 | ENST00000377636.8 | NP_055647.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBC1D4 | ENST00000377636.8 | c.3391A>G | p.Ile1131Val | missense_variant | 19/21 | 2 | NM_014832.5 | ENSP00000366863.3 | ||
TBC1D4 | ENST00000431480.6 | c.3367A>G | p.Ile1123Val | missense_variant | 18/20 | 1 | ENSP00000395986.2 | |||
TBC1D4 | ENST00000377625.6 | c.3202A>G | p.Ile1068Val | missense_variant | 17/19 | 1 | ENSP00000366852.2 | |||
TBC1D4 | ENST00000648194.1 | c.2659A>G | p.Ile887Val | missense_variant | 18/20 | ENSP00000496983.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152210Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
40
AN:
152210
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000639 AC: 159AN: 248994Hom.: 1 AF XY: 0.000837 AC XY: 113AN XY: 135084
GnomAD3 exomes
AF:
AC:
159
AN:
248994
Hom.:
AF XY:
AC XY:
113
AN XY:
135084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000335 AC: 490AN: 1461256Hom.: 3 Cov.: 31 AF XY: 0.000455 AC XY: 331AN XY: 726930
GnomAD4 exome
AF:
AC:
490
AN:
1461256
Hom.:
Cov.:
31
AF XY:
AC XY:
331
AN XY:
726930
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000263 AC: 40AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000430 AC XY: 32AN XY: 74494
GnomAD4 genome
AF:
AC:
40
AN:
152328
Hom.:
Cov.:
32
AF XY:
AC XY:
32
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
99
Asia WGS
AF:
AC:
18
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
TBC1D4-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 25, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;.;M
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;N;N
REVEL
Benign
Sift
Benign
.;T;T;T
Sift4G
Uncertain
.;D;D;D
Polyphen
0.0010
.;B;B;B
Vest4
0.28, 0.19, 0.18
MutPred
0.56
.;.;.;Gain of catalytic residue at M1132 (P = 0);
MVP
0.50
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at